SCHEMBL13499152

SCHEMBL13499152

CC(C)(C)[Si](OCCc1ncc2c(n1)CCCC2N=[N+]=[N-])(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMYD2 Q9NRG4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531398 0.83 SMYD2 (0.34) SMYD2
SCHEMBL3535876 0.83 GRM5 (0.37) SMYD2
SCHEMBL13499977 0.79 HTR2C (0.32)
SCHEMBL3537044 0.73 SMN1; SMN2 (0.42) SMYD2
SCHEMBL28723954 0.66 SMYD2 (0.35) SMYD2
SCHEMBL22247591 0.65 RIPK1 (0.33) SMYD2
SCHEMBL13696122 0.64 SMYD2 (0.32) SMYD2
SCHEMBL23528479 0.63 SMYD2 (0.36) SMYD2
SCHEMBL16259098 0.63 SMYD2 (0.36) SMYD2
SCHEMBL15018595 0.63 SMYD2 (0.36) SMYD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662811-B2 N-(((5R)-5-((1-methylethyl)amino)-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-2-((2R)-1-((4-methylphenyl)sulfonyl)-3-oxo-1,2,3,4-tetrahydro-2-pyrazinyl)acetamide; for treatment of pain and diseases, such as inflammation mediated diseases AMGEN INC. (US) 2010-02-16 US disclosed
US-7612060-B2 Triazoles and methods of use AMGEN INC. (US) 2009-11-03 US disclosed